Stock ACOU ACOUSORT AB
Add to a list
To use this feature you must be a member
Log inSign up

All News AcouSort AB

Equities

ACOU

SE0009189608

Market Closed - Nasdaq Stockholm
Other stock markets
 11:03:37 2024-05-16 EDT 		5-day change 1st Jan Change
10.05 SEK +2.55% Intraday chart for AcouSort AB -5.19% -35.37%
05-02 AcouSort AB to Present Two Posters Highlighting the Value of Acoustofluidics Sample Preparation CI
04-29 AcouSort AB and GenSensor SAS Enters Collaboration Aiming At Improving Bioreactor Culturing CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AcouSort will exhibit and present at CYTO 2024 – demonstrating the benefits of acoustic sample preparation for flow cytometry applications
AQ
AcouSort AB to Present Two Posters Highlighting the Value of Acoustofluidics Sample Preparation
CI
Communiqué from the annual general meeting of AcouSort AB (publ)
AQ
AcouSort and Gensensor enter collaboration aiming at improving bioreactor culturing
AQ
AcouSort AB and GenSensor SAS Enters Collaboration Aiming At Improving Bioreactor Culturing
CI
AcouWash placed at two potential OEM partners
AQ
AcouSort Initiates Two AcouWash Lease Collaborations with Potential OEM Partners
CI
Increased interest for AcouTrap EV isolation for nano flow cytometry applications
AQ
AcouSort restructures its North American sales operation
AQ
AcouSort AB Annual report 2023
AQ
AcouSort AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Shareholder interview with AcouSort’s CEO Torsten Freltoft and Commercial Director Agnes Michanek
AQ
Year end report for AcouSort AB 1 January - 31 December 2023
AQ
Significant technical progress in the AcouSome project – two novel patent applications filed
AQ
AcouSort extends collaboration with leading cell therapy company into a third project phase
AQ
AcouSort attends Advanced Therapies Week to extend its cell therapy network
AQ
AcouSort : The board of directors resolves to repurchase warrants series 2020/2023
PU
AcouSort's rights issue is registered - conversion of BTU into shares and warrants
AQ
FDA approval paves the way for AcouSort's first OEM commercialization within critical care diagnostics
AQ
AcouSort : rights issue fully subscribed
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACOU Stock
  4. News AcouSort AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW